Botulinum Toxin A Treatment in HIV Infected Patients—A Long-Term Observational Study

Objective: It is unknown whether interactions between HIV infection and the safety of botulinum toxin A (BTX) exist. Methods: We studied eight patients with HIV infection who were treated with BTX every three months for up to nine years. All patients were on antiretroviral treatment. The efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Evers, Stefan, Buchheister, Alexandra, Reichelt, Doris, Husstedt, Ingo W., Frese, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029356/
https://www.ncbi.nlm.nih.gov/pubmed/35456289
http://dx.doi.org/10.3390/jcm11082197

Ejemplares similares

Ejemplares similares